Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice

Colin Selman, Steven Lingard, Agharul I. Choudhury, Rachel L. Batterham, Marc Claret, Melanie Clements, Faruk Ramadani, Klaus Okkenhaug, Eugene Schuster, Eric Blanc, Matthew D. Piper, Hind Al-Qassab, John R. Speakman, Danielle Carmignac, Iain C. A. Robinson, Janet M. Thornton, David Gems, Linda Partridge, Dominic J. Withers

Research output: Contribution to journalArticle

336 Citations (Scopus)

Abstract

Recent evidence suggests that alterations in insulin/insulin-like growth factor 1 (IGF1) signaling (IIS) can increase mammalian life span. For example, in several mouse mutants, impairment of the growth hormone (GH)/IGF1 axis increases life span and also insulin sensitivity. However, the intracellular signaling route to altered mammalian aging remains unclear. We therefore measured the life span of mice lacking either insulin receptor substrate (IRS) 1 or 2, the major intracellular effectors of the IIS receptors. Our provisional results indicate that female Irs1(-/-) mice are long-lived. Furthermore, they displayed resistance to a range of age-sensitive markers of aging including skin, bone, immune, and motor dysfunction. These improvements in health were seen despite mild, lifelong insulin resistance. Thus, enhanced insulin sensitivity is not a prerequisite for IIS mutant longevity. Irs1(-/-) female mice also displayed normal anterior pituitary function, distinguishing them from long-lived somatotrophic axis mutants. In contrast, Irs2(-/-) mice were short-lived, whereas Irs1(+/-) and Irs2(+/-) mice of both sexes showed normal life spans. Our results therefore suggest that IRS1 signaling is an evolutionarily conserved pathway regulating mammalian life span and may be a point of intervention for therapies with the potential to delay age-related processes.

Original languageEnglish
Pages (from-to)807-818
Number of pages12
JournalThe FASEB Journal
Volume22
Issue number3
Early online date10 Oct 2007
DOIs
Publication statusPublished - Mar 2008

Keywords

  • aging
  • longevity
  • insulin signaling
  • insulin-receptor gene
  • caloric restriction
  • caenorhabditis-elegans
  • dwarf mice
  • mouse models
  • body-weight
  • expression
  • IGF-1
  • insights

Cite this

Selman, C., Lingard, S., Choudhury, A. I., Batterham, R. L., Claret, M., Clements, M., ... Withers, D. J. (2008). Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. The FASEB Journal, 22(3), 807-818. https://doi.org/10.1096/fj.07-9261com

Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. / Selman, Colin; Lingard, Steven; Choudhury, Agharul I.; Batterham, Rachel L.; Claret, Marc; Clements, Melanie; Ramadani, Faruk; Okkenhaug, Klaus; Schuster, Eugene; Blanc, Eric; Piper, Matthew D.; Al-Qassab, Hind; Speakman, John R.; Carmignac, Danielle; Robinson, Iain C. A.; Thornton, Janet M.; Gems, David; Partridge, Linda; Withers, Dominic J.

In: The FASEB Journal, Vol. 22, No. 3, 03.2008, p. 807-818.

Research output: Contribution to journalArticle

Selman, C, Lingard, S, Choudhury, AI, Batterham, RL, Claret, M, Clements, M, Ramadani, F, Okkenhaug, K, Schuster, E, Blanc, E, Piper, MD, Al-Qassab, H, Speakman, JR, Carmignac, D, Robinson, ICA, Thornton, JM, Gems, D, Partridge, L & Withers, DJ 2008, 'Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice', The FASEB Journal, vol. 22, no. 3, pp. 807-818. https://doi.org/10.1096/fj.07-9261com
Selman, Colin ; Lingard, Steven ; Choudhury, Agharul I. ; Batterham, Rachel L. ; Claret, Marc ; Clements, Melanie ; Ramadani, Faruk ; Okkenhaug, Klaus ; Schuster, Eugene ; Blanc, Eric ; Piper, Matthew D. ; Al-Qassab, Hind ; Speakman, John R. ; Carmignac, Danielle ; Robinson, Iain C. A. ; Thornton, Janet M. ; Gems, David ; Partridge, Linda ; Withers, Dominic J. / Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. In: The FASEB Journal. 2008 ; Vol. 22, No. 3. pp. 807-818.
@article{324a17bd98064d33a5389ad16dfce79f,
title = "Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice",
abstract = "Recent evidence suggests that alterations in insulin/insulin-like growth factor 1 (IGF1) signaling (IIS) can increase mammalian life span. For example, in several mouse mutants, impairment of the growth hormone (GH)/IGF1 axis increases life span and also insulin sensitivity. However, the intracellular signaling route to altered mammalian aging remains unclear. We therefore measured the life span of mice lacking either insulin receptor substrate (IRS) 1 or 2, the major intracellular effectors of the IIS receptors. Our provisional results indicate that female Irs1(-/-) mice are long-lived. Furthermore, they displayed resistance to a range of age-sensitive markers of aging including skin, bone, immune, and motor dysfunction. These improvements in health were seen despite mild, lifelong insulin resistance. Thus, enhanced insulin sensitivity is not a prerequisite for IIS mutant longevity. Irs1(-/-) female mice also displayed normal anterior pituitary function, distinguishing them from long-lived somatotrophic axis mutants. In contrast, Irs2(-/-) mice were short-lived, whereas Irs1(+/-) and Irs2(+/-) mice of both sexes showed normal life spans. Our results therefore suggest that IRS1 signaling is an evolutionarily conserved pathway regulating mammalian life span and may be a point of intervention for therapies with the potential to delay age-related processes.",
keywords = "aging, longevity, insulin signaling, insulin-receptor gene, caloric restriction, caenorhabditis-elegans, dwarf mice, mouse models, body-weight, expression, IGF-1, insights",
author = "Colin Selman and Steven Lingard and Choudhury, {Agharul I.} and Batterham, {Rachel L.} and Marc Claret and Melanie Clements and Faruk Ramadani and Klaus Okkenhaug and Eugene Schuster and Eric Blanc and Piper, {Matthew D.} and Hind Al-Qassab and Speakman, {John R.} and Danielle Carmignac and Robinson, {Iain C. A.} and Thornton, {Janet M.} and David Gems and Linda Partridge and Withers, {Dominic J.}",
year = "2008",
month = "3",
doi = "10.1096/fj.07-9261com",
language = "English",
volume = "22",
pages = "807--818",
journal = "The FASEB Journal",
issn = "0892-6638",
publisher = "FEDERATION AMER SOC EXP BIOL",
number = "3",

}

TY - JOUR

T1 - Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice

AU - Selman, Colin

AU - Lingard, Steven

AU - Choudhury, Agharul I.

AU - Batterham, Rachel L.

AU - Claret, Marc

AU - Clements, Melanie

AU - Ramadani, Faruk

AU - Okkenhaug, Klaus

AU - Schuster, Eugene

AU - Blanc, Eric

AU - Piper, Matthew D.

AU - Al-Qassab, Hind

AU - Speakman, John R.

AU - Carmignac, Danielle

AU - Robinson, Iain C. A.

AU - Thornton, Janet M.

AU - Gems, David

AU - Partridge, Linda

AU - Withers, Dominic J.

PY - 2008/3

Y1 - 2008/3

N2 - Recent evidence suggests that alterations in insulin/insulin-like growth factor 1 (IGF1) signaling (IIS) can increase mammalian life span. For example, in several mouse mutants, impairment of the growth hormone (GH)/IGF1 axis increases life span and also insulin sensitivity. However, the intracellular signaling route to altered mammalian aging remains unclear. We therefore measured the life span of mice lacking either insulin receptor substrate (IRS) 1 or 2, the major intracellular effectors of the IIS receptors. Our provisional results indicate that female Irs1(-/-) mice are long-lived. Furthermore, they displayed resistance to a range of age-sensitive markers of aging including skin, bone, immune, and motor dysfunction. These improvements in health were seen despite mild, lifelong insulin resistance. Thus, enhanced insulin sensitivity is not a prerequisite for IIS mutant longevity. Irs1(-/-) female mice also displayed normal anterior pituitary function, distinguishing them from long-lived somatotrophic axis mutants. In contrast, Irs2(-/-) mice were short-lived, whereas Irs1(+/-) and Irs2(+/-) mice of both sexes showed normal life spans. Our results therefore suggest that IRS1 signaling is an evolutionarily conserved pathway regulating mammalian life span and may be a point of intervention for therapies with the potential to delay age-related processes.

AB - Recent evidence suggests that alterations in insulin/insulin-like growth factor 1 (IGF1) signaling (IIS) can increase mammalian life span. For example, in several mouse mutants, impairment of the growth hormone (GH)/IGF1 axis increases life span and also insulin sensitivity. However, the intracellular signaling route to altered mammalian aging remains unclear. We therefore measured the life span of mice lacking either insulin receptor substrate (IRS) 1 or 2, the major intracellular effectors of the IIS receptors. Our provisional results indicate that female Irs1(-/-) mice are long-lived. Furthermore, they displayed resistance to a range of age-sensitive markers of aging including skin, bone, immune, and motor dysfunction. These improvements in health were seen despite mild, lifelong insulin resistance. Thus, enhanced insulin sensitivity is not a prerequisite for IIS mutant longevity. Irs1(-/-) female mice also displayed normal anterior pituitary function, distinguishing them from long-lived somatotrophic axis mutants. In contrast, Irs2(-/-) mice were short-lived, whereas Irs1(+/-) and Irs2(+/-) mice of both sexes showed normal life spans. Our results therefore suggest that IRS1 signaling is an evolutionarily conserved pathway regulating mammalian life span and may be a point of intervention for therapies with the potential to delay age-related processes.

KW - aging

KW - longevity

KW - insulin signaling

KW - insulin-receptor gene

KW - caloric restriction

KW - caenorhabditis-elegans

KW - dwarf mice

KW - mouse models

KW - body-weight

KW - expression

KW - IGF-1

KW - insights

U2 - 10.1096/fj.07-9261com

DO - 10.1096/fj.07-9261com

M3 - Article

VL - 22

SP - 807

EP - 818

JO - The FASEB Journal

JF - The FASEB Journal

SN - 0892-6638

IS - 3

ER -